Cory Rillahan, MD, PhD

Physician, Cancer and Blood Disorders Center
Instructor of Pediatrics, Harvard Medical School
Faceless Avatar - Male
Phone 617-632-3270
Fax 617-632-4410
NPI 1821557117
Print Profile
Request an Appointment
Locations

Cory Rillahan, MD, PhD

Physician, Cancer and Blood Disorders Center
Instructor of Pediatrics, Harvard Medical School

Medical Services

Programs & Services
Cancer and Blood Disorders Center
Conditions & Treatments
Anemia
Leukemia
Lymphoblastic Lymphoma
Myelodysplastic Syndrome
Sickle Cell Disease
Languages
English
Education
Graduate School
cripps Research Institute
2012
San Diego
CA
Medical School
New York University
2019
New York
NY
Residency
Boston Children’s Hospital/Boston Medical Center
2022
Boston
MA
Fellowship
Boston Children’s Hospital/Dana Farber Cancer Institute
2025
Boston
MA
Certifications
American Board of Pediatrics (General)
Approach to Care
I am an attending pediatric oncologist and physician scientist interested in the discovery and design of new therapeutic agents for pediatric cancers.

Publications

A vital sugar code for ricin toxicity. View Abstract
Deletions linked to TP53 loss drive cancer through p53-independent mechanisms. View Abstract
Cooperative loss of RAS feedback regulation drives myeloid leukemogenesis. View Abstract
Janus kinase inhibition by ruxolitinib extends dasatinib- and dexamethasone-induced remissions in a mouse model of Ph+ ALL. View Abstract
Systemic blockade of sialylation in mice with a global inhibitor of sialyltransferases. View Abstract
Targeted delivery of mycobacterial antigens to human dendritic cells via Siglec-7 induces robust T cell activation. View Abstract
Disubstituted Sialic Acid Ligands Targeting Siglecs CD33 and CD22 Associated with Myeloid Leukaemias and B Cell Lymphomas. View Abstract
On-chip synthesis and screening of a sialoside library yields a high affinity ligand for Siglec-7. View Abstract
Click and pick: identification of sialoside analogues for siglec-based cell targeting. View Abstract
Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome. View Abstract
High-throughput screening for inhibitors of sialyl- and fucosyltransferases. View Abstract
Glycan microarrays for decoding the glycome. View Abstract
Bifunctional CD22 ligands use multimeric immunoglobulins as protein scaffolds in assembly of immune complexes on B cells. View Abstract
Locations